IRIS
NOBILI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.888
AS - Asia 1.854
EU - Europa 1.729
SA - Sud America 664
AF - Africa 46
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
AN - Antartide 1
Totale 6.187
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.821
SG - Singapore 976
RU - Federazione Russa 896
BR - Brasile 546
IE - Irlanda 325
VN - Vietnam 309
CN - Cina 302
SE - Svezia 199
IT - Italia 132
HK - Hong Kong 67
IN - India 52
AR - Argentina 45
DE - Germania 43
GB - Regno Unito 33
CA - Canada 32
BD - Bangladesh 31
ID - Indonesia 29
MX - Messico 24
EC - Ecuador 21
AT - Austria 18
PL - Polonia 15
PY - Paraguay 14
CO - Colombia 13
IQ - Iraq 13
TR - Turchia 13
ZA - Sudafrica 13
UA - Ucraina 12
ES - Italia 9
PK - Pakistan 9
FI - Finlandia 7
KE - Kenya 7
MA - Marocco 7
UY - Uruguay 7
VE - Venezuela 7
LT - Lituania 6
PE - Perù 6
TN - Tunisia 6
BE - Belgio 5
FR - Francia 5
KR - Corea 5
RO - Romania 5
UZ - Uzbekistan 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
JP - Giappone 4
NL - Olanda 4
SA - Arabia Saudita 4
AL - Albania 3
BH - Bahrain 3
CL - Cile 3
DO - Repubblica Dominicana 3
EG - Egitto 3
EU - Europa 3
JO - Giordania 3
NP - Nepal 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
HN - Honduras 2
IR - Iran 2
JM - Giamaica 2
KZ - Kazakistan 2
MN - Mongolia 2
PH - Filippine 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
ET - Etiopia 1
GI - Gibilterra 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
ME - Montenegro 1
MU - Mauritius 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PW - Palau 1
RS - Serbia 1
Totale 6.187
Salva come PNG Salva come JPEG
Città #
Singapore 699
Dublin 325
San Jose 270
Princeton 172
Beijing 161
Dallas 138
Ashburn 124
Santa Clara 119
Ho Chi Minh City 113
Altamura 90
Jacksonville 81
Hanoi 74
Hong Kong 62
Wilmington 56
São Paulo 50
Los Angeles 47
Buffalo 33
Redondo Beach 33
New York 28
Rio de Janeiro 24
Chandler 22
Moscow 21
Nuremberg 19
The Dalles 17
Chicago 16
Curitiba 15
Haiphong 15
Norwalk 15
Council Bluffs 14
London 14
Chennai 13
Dong Ket 12
Mexico City 12
Denver 11
Guayaquil 10
Montreal 10
Manchester 9
Mumbai 9
Munich 8
Orem 8
Porto Alegre 8
Toronto 8
Brooklyn 7
Johannesburg 7
Phoenix 7
San Francisco 7
Thái Bình 7
Vienna 7
Warsaw 7
Belo Horizonte 6
Boston 6
Frankfurt am Main 6
Istanbul 6
Milan 6
Montevideo 6
Nairobi 6
Santa Fe 6
Stockholm 6
Uberlândia 6
Bauru 5
Brasília 5
Brussels 5
Fortaleza 5
Guarulhos 5
New Delhi 5
Phủ Lý 5
Salvador 5
Seoul 5
Sorocaba 5
Ankara 4
Brno 4
Buenos Aires 4
Bắc Giang 4
Charlotte 4
Da Nang 4
Dhaka 4
Hangzhou 4
Hefei 4
Helsinki 4
Hải Dương 4
José C. Paz 4
Osasco 4
Poplar 4
Recife 4
Romola 4
Santo André 4
São José dos Pinhais 4
Tashkent 4
Amsterdam 3
Aparecida de Goiânia 3
Araraquara 3
Asunción 3
Atlanta 3
Baghdad 3
Belford Roxo 3
Bình Dương 3
Calgary 3
Campinas 3
Campos dos Goytacazes 3
Can Tho 3
Totale 3.256
Salva come PNG Salva come JPEG
Nome #
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 786
2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds 147
Optimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action 107
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 107
Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents 104
An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC) 102
A potential novel drug combination for adjuvant therapy in lung cancer: reflections on an early phase of clinical development 98
Clinical outcomes and safety of patients treated with NAb-Paclitaxel plus Gemcitabine in metastatic pancreatic cancer: the NAPA study 95
A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy 93
Association of the HLA-G 3′UTR polymorphisms with colorectal cancer in Italy: A first insight 92
Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy 89
DPYD gene activity score (GAS) predicts dose-limiting toxicity in fluoropyrimidine-treated colorectal cancer patients 86
Druggable targets in pancreatic adenocarcinoma 83
Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds 81
Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer 80
Does surgical prophylaxis with teicoplanin constitute a therapeutic advance? 77
Chronic inflammation in urothelial bladder cancer 77
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 76
Efficacy evaluation of plant products in the treatment of erectile dysfunction related to diabetes 76
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 75
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines 75
Cellular pharmacology of gemcitabine 74
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer 73
Specific markers, micro-environmental anomalies and tropism: opportunities for gold nanorods targeting of tumors in laser-induced hyperthermia 73
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice 72
TRK fusion positive cancers: From first clinical data of a TRK inhibitor to future directions 70
Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: A pilot study 70
Insights into the role of matrix metalloproteinases in precancerous conditions and in colorectal cancer 70
Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer 69
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors 69
Prognostic factors in primary and iterative surgery of colorectal liver metastases 69
PNN and KCNQ1OT1 Can Predict the Efficacy of Adjuvant Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer Patients 69
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression 68
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 67
Oxaliplatin plus Raltitrexed in the treatment of patients with advanced colorectal cancer: A phase II study 67
Some suggestions from pk/pd principles to contain resistance in the clinical setting—focus on icu patients and gram-negative strains 66
Proteomic analysis of the cytotoxic effects induced by the organogold(iii) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication 66
HLA-G 3'UTR polymorphisms impact the prognosis of stage II-III CRC patients in fluoropyrimidine-based treatment 66
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 65
Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(ii) compounds with sulfur and phosphorus donors 64
Immune checkpoint inhibitors in pre-treated gastric cancer patients: Results from a literature-based meta-analysis 64
Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment 63
Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study 63
Transcriptional subtyping and CD8 immunohistochemistry identifies patients with stage II and III colorectal cancer with poor prognosis who benefit from adjuvant chemotherapy 63
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer 63
Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2′-pyridyl)benzimidazole as ligand: Comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives 63
Natural compounds for cancer treatment and prevention 63
Postoperative chemotherapy in resected gastric cancer: Results of a single center experience 63
Size dependent biological profiles of PEGylated gold nanorods 62
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer 62
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, In combination with cisplatin In patients with advanced non-small-cell lung cancer 62
Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma 61
Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma 61
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer 60
In vitro study on the safety of near infrared laser therapy in its potential application as postmastectomy lymphedema treatment 60
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 60
Genomic and genetic alterations infuence the progression of gastric cancer 60
Establishment and characterization of a new spontaneously immortalized ER -/PR -/HER2 + human breast cancer cell line, DHSF-BR16 60
Vinorelbine in non-small cell lung cancer: Real-world data from a single-institution experience 59
Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis? 59
Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand 59
The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics 58
Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules 58
Oxaliplatinum and 5-fluorouracil in protracted infusion in the treatment of advanced colorectal cancer 57
Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil 56
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipyc 55
Pharmacogenetics: Implementing personalized medicine 55
The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways 54
Emerging drugs in refractory colorectal cancer 54
TAS-102 in gastric cancer: Development and perspectives of a new biochemically modulated fluroropyrimidine drug combination 53
Editorial: Multidrug resistance in cancer: Pharmacological strategies from basic research to clinical issues 53
Gold compounds as anticancer agents: Chemistry, cellular pharmacology, and preclinical studies 53
Role of ATP-binding cassette transporters in cancer initiation and progression 51
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: Solution behavior, reactions with model proteins, antiproliferative properties 51
Focus on biochemical and clinical predictors of response to immune checkpoint inhibitors in metastatic urothelial carcinoma: Where do we stand? 51
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge 51
Pharmacological strategies for overcoming multidrug resistance 50
Exploring the biochemical mechanisms of cytotoxic gold compounds: A proteomic study 49
Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer 48
Increased Expression of VANGL1 is Predictive of Lymph Node Metastasis in Colorectal Cancer: Results from a 20-Gene Expression Signature 48
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 45
In vitro assessment of antibody-conjugated gold nanorods for systemic injections 45
Maintenance in gastric cancer: New life for an old issue? 44
Role of novel hormonal therapies in the management of non-metastatic castration-resistant prostate cancer: a literature-based meta-analysis of randomized trials 43
Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties 38
Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopedic surgery 38
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer 37
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 37
Totale 6.535
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.413
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202154 0 0 0 0 0 0 0 0 0 13 14 27
2021/2022214 1 4 3 2 4 0 2 21 28 6 50 93
2022/2023568 98 98 79 1 3 147 68 21 44 6 3 0
2023/2024304 12 27 20 18 12 82 98 0 0 5 8 22
2024/20251.419 103 464 295 11 37 8 43 39 163 65 96 95
2025/20263.576 173 266 471 575 213 146 351 187 964 230 0 0
Totale 6.535